West Pharmaceutical Services, Inc. logo

West Pharmaceutical Services, Inc. (WPS)

Market Closed
17 Jul, 06:07
XMUN XMUN
314. 20
+0.8
+0.2553%
- Market Cap
49.01 P/E Ratio
0.88% Div Yield
30 Volume
7.62 Eps
313.4
Previous Close
Add Transaction
Day Range
314.2 314.2
Year Range
181.5 318.35
Want to track WPS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

WPS closed Friday higher at €314.2, an increase of 0.2553% from Thursday's close, completing a monthly increase of 0.5762% or €1.8. Over the past 12 months, WPS stock gained 35.3727%.
WPS pays dividends to its shareholders, with the most recent payment made on May 06, 2026. The next estimated payment will be in In 2 weeks on Aug 06, 2026 for a total of €0.22.
The last earnings report, released on Apr 23, 2026, missed the consensus estimates by -1.68%. On average, the company has fell short of earnings expectations by -0.3967%, based on the last three reports.
West Pharmaceutical Services, Inc. has completed 4 stock splits, with the recent split occurring on Sep 27, 2013.
The company's stock is traded on 9 different exchanges and in various currencies, with the primary listing on NYSE (USD).

WPS Chart

West Pharmaceutical Services (WST) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

West Pharmaceutical Services (WST) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

West Pharmaceutical (WST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 2 days ago
Reasons to Add West Pharmaceutical Stock to Your Portfolio Now

Reasons to Add West Pharmaceutical Stock to Your Portfolio Now

West Pharmaceutical Services, Inc.  WST is well positioned for growth, backed by strong demand for HVPs, expanding GLP-1 drug programs and regulatory-driven Annex 1 conversions. However, tariff impacts, destocking in generics and execution challenges at constrained European facilities are concerning.

Zacks | 3 days ago
WST Completes SmartDose Sale to AbbVie to Focus on Core Growth

WST Completes SmartDose Sale to AbbVie to Focus on Core Growth

West Pharmaceutical completes the SmartDose 3.5mL sale to AbbVie, sharpening its focus on higher-growth on-body drug delivery technologies.

Zacks | 1 week ago

West Pharmaceutical Services, Inc. (WPS) FAQ

What is the stock price today?

The current price is €314.20.

On which exchange is it traded?

West Pharmaceutical Services, Inc. is listed on XMUN.

What is its stock symbol?

The ticker symbol is WPS.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.88%.

What is its market cap?

As of today, no market cap data is available.

Has West Pharmaceutical Services, Inc. ever had a stock split?

West Pharmaceutical Services, Inc. had 4 splits and the recent split was on Sep 27, 2013.

West Pharmaceutical Services, Inc. Profile

Electronic Equipment, Instruments & Components Industry
Information Technology Sector
Eric Green CEO
XMUN Exchange
US9553061055 ISIN
US Country
10,600 Employees
6 May 2026 Last Dividend
27 Sep 2013 Last Split
13 Jan 1978 IPO Date

Overview

West Pharmaceutical Services, Inc. is a leading global provider in the design, manufacturing, and sale of containment and delivery systems for injectable drugs and healthcare products. With a presence across the Americas, Europe, the Middle East, Africa, and the Asia Pacific, the company operates through two primary segments: Proprietary Products and Contract-Manufactured Products. Founded in 1923 and headquartered in Exton, Pennsylvania, West Pharmaceutical Services, Inc. is dedicated to serving biologic, generic, and pharmaceutical drug companies, as well as pharmaceutical, diagnostic, and medical device companies through a comprehensive sales force, distribution network, contract sales agents, and regional distributors.

Products and Services

  • Stoppers and Seals for Injectable Packaging Systems: These are designed for use in vials and other packaging systems to ensure the integrity and sterility of injectable drugs.
  • Syringe and Cartridge Components: This includes custom solutions for injectable drug applications, offering enhanced safety and efficiency in drug delivery through advanced technologies in reconstitution, mixing, and transfer.
  • Films, Coatings, Washing, Vision Inspection, and Sterilization Services: These services aim to improve the quality of packaging components, ensuring that they meet stringent healthcare standards.
  • Drug Containment Solutions: Among their offerings is Crystal Zenith, a high-performance cyclic olefin polymer used in formulating vials, syringes, and cartridges. This product line is geared towards providing superior containment solutions for sensitive biologics and other pharmaceuticals.
  • Self-Injection Devices: These devices are designed to facilitate self-administration of drugs, improving patient compliance and convenience. West also offers a variety of integrated services such as analytical lab services, pre-approval primary packaging support, engineering development, regulatory expertise, and after-sales technical support to complement these offerings.
  • Design, Manufacture, and Automated Assembly of Devices: Within their Contract-Manufactured Products segment, the focus is on creating devices for surgical, diagnostic, ophthalmic, injectable, and various drug delivery systems, as well as consumer products. This entails a close collaboration with pharmaceutical, diagnostic, and medical device companies to develop solutions that meet specific requirements.

Contact Information

Address: 530 Herman O. West Drive
Phone: 610 594 2900